Biotech | April 05, 2022
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Supply increase to help meet growing global demand
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
BVX-0922 to target colorectal cancer under investigator-sponsored IND
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
Vault PromoMats helps life sciences companies speed the creation, review, and distribution of compliant content. Built-in digital asset management enables content reuse and reduces spend on promotional materials
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
The expansion makes Exothera one of the largest viral vector facilities in Europe
Subscribe To Our Newsletter & Stay Updated
